Physician profile
Simon N Donets
NPI 1568432094
$4,038.27
in general payments reported to CMS, 2019-2025
31 companies · $1,687 in 2025
The $1,687 reported for 2025 was more than what 88% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $281 · 2021: $106 · 2022: $229 · 2023: $1,046 · 2024: $460 · 2025: $1,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,419 · Debt Forgiveness: $860 · Food and Beverage: $651 · Consulting Fee: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,419.21 |
| Debt Forgiveness | $859.84 |
| Food and Beverage | $651.01 |
| Consulting Fee | $262.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,558.97 | 2025 | Prostep, Prostep Mica, Ortholoc 3di |
| Djo, LLC | $859.84 | 2023 | |
| Fusion Orthopedics USA, LLC | $280.35 | 2024 | |
| Smith+Nephew, INC. | $186.06 | 2019-2024 | Grafix, Stravix Pl, Grafix Pl |
| Paragon 28, INC. | $170.85 | 2023-2025 | Bun-Yo-Matic, Mtp, Ankle Fracture |
| Organogenesis INC. | $130.68 | 2019-2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $118.35 | 2022-2025 | Nuzyra |
| Sunovion Pharmaceuticals INC. | $77.52 | 2020-2021 | |
| Bioventus LLC | $66.82 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Osteomed LLC | $57.36 | 2020-2021 | |
| Melinta Therapeutics, LLC | $57.15 | 2020-2021 | |
| Orthofix Medical, INC. | $55.63 | 2023-2025 | Physio-Stim |
| Lilly USA, LLC | $46.91 | 2022 | |
| Janssen Pharmaceuticals, INC | $45.86 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $37.08 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $31.67 | 2024 | Krystexxa |
| Abbott Laboratories | $23.70 | 2023 | Proclaim |
| Allergan, INC. | $20.37 | 2020 | |
| Zimmer Biomet Holdings, INC. | $19.71 | 2019 | |
| Wright Medical Technology, INC. | $18.85 | 2019 | |
| Horizon Therapeutics Plc | $18.83 | 2020 | |
| Baudax Bio INC. | $17.78 | 2022 | |
| Novum Pharma, LLC | $17.72 | 2019 | |
| Novo Nordisk INC | $17.29 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.90 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.57 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $15.12 | 2021 | |
| Fidia Pharma USA INC. | $14.55 | 2019 | |
| Treace Medical Concepts, INC. | $13.90 | 2023 | |
| Next Science LLC | $13.24 | 2023 | Surgx, Xperience, Blastx |
| Acera Surgical, INC. | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Donets listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.